Effects of liraglutide treatment for 18 days on metabolic parameters, regional body composition and the myostatin–activin–follistatin– IGF ‐1 axis: Results from an exploratory, randomized, placebo‐controlled, crossover study

Documents similaires

• Comment on “Effects of liraglutide treatment for 18 days on metabolic parameters, regional body composition and the myostatin–activin–follistatin– IGF ‐1 axis”
  par: Caoxu Zhang, et autres
  Publié: (2025)
• Apolipoprotein CIII correlates with lipoproteins in the fed state and is not regulated by leptin administration in states of hypoleptinemia induced by acute or chronic energy deficiency: Results from two randomised controlled trials
  par: Arantxa Ramirez‐Cisneros, et autres
  Publié: (2025)
• Total and H‐specific growth/differentiation factor 15 levels are unaffected by liraglutide or naltrexone/bupropion administration
  par: Sofia K. Konstantinidou, et autres
  Publié: (2024)
• The impact of metformin on weight and metabolic parameters in patients with obesity: A systematic review and meta‐analysis of randomized controlled trials
  par: Rachelle Haber, et autres
  Publié: (2024)
• Rapid improvement of renal microcirculatory homeostasis by liraglutide following diabetes induction
  par: Yuan Li, et autres
  Publié: (2026)